Simulations Plus today reported preliminary revenues for its third fiscal quarter of $3.1 million — a nearly 15 percent increase over the prior-year period and the first quarter in which the firm generated more than $3 million in revenue.
For the three-month period ended May 31, preliminary revenues for the company's pharmaceutical software and services business increased 17 percent year-over-year to $2.3 million, while revenues for its Words+ subsidiary rose 9 percent to $794,000.
Simulations Plus said that it expects to file its quarterly report with the US Securities and Exchange Commission and release its final earnings statement in mid-July.